Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Purpose of review Endometriosis is a gynecologic disorder that can lead to debilitating chronic pelvic pain and infertility. Gonadotropin-releasing hormone agonists (GnRHa) have emerged as a primary medical therapy for patients with symptomatic disease, but secondary hypoestrogenic side effects may limit compliance. Add-back therapy is a means of surmounting this problem. Recent findings Progestins such as norethindrone acetate may be administered with or without addition of low doses of estrogens to safely and effectively extend GnRHa therapy while minimizing side effects. Recent studies have demonstrated that the use of add-back enhances compliance and duration of therapy. The initiation of an add-back should not be deferred given evidence demonstrating an increase in vasomotor symptoms and bone loss if not administered concomitantly. The subset of adolescents with endometriosis who require GnRHa therapy should be administered an add-back, but require careful monitoring of bone mineral density. Summary Implementation of an appropriately selected add-back will significantly reduce hypoestrogenic side effects, enhance compliance, and allow for prolongation of therapy without interfering with the efficacy of GnRHa in treating symptomatic endometriosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The association of GnRH agonists with hormonal add-back therapy prevents bone loss without decreasing their efficacy (Surrey et al., 2010).”
From When more is not better: 10 ‘don’ts’ in endometriosis management. An ETIC* position statement (2019) · cites this paper as Surrey et al., 2010
Citations
Cites
Aromatase expression in endometriosis.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550748 · Cited by 566
Laufer, M. R., Goitein, L., Bush, M., Cramer, D. W., & Emans, S. J. (1997) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/s1083-3188(97)70085-8 · Cited by 310
Epidemiology of endometriosis-associated infertility.
Wheeler, J. M. (1989) · PubMed · Cited by 270
Estrogen Receptor-β, Estrogen Receptor-α, and Progesterone Resistance in Endometriosis
Bulun, S., Cheng, Y.-H., Pavone, M., Xue, Q., Attar, E., Trukhacheva, E., Tokunaga, H., Utsunomiya, H., Yin, P., Luo, X., et al. (2010) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1242991 · Cited by 243
Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study
Hornstein, M. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00620-0 · Cited by 243
Self-citationProlonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1
SURREY, E. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)01945-2 · Cited by 169
Self-citationAdd-back therapy in the treatment of endometriosis-associated pain
Zupi, E., Marconi, D., Sbracia, M., Zullo, F., De Vivo, B., Exacustos, C., & Sorrenti, G. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.03.062 · Cited by 103
Sharpe-Timms, K. L., Keisler, L. W., McIntush, E. W., & Keisler, D. H. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00075-2 · Cited by 100
Moghissi, K. S., Schlaff, W. D., Olive, D. L., Skinner, M. A., & Yin, H. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00086-7 · Cited by 96
Meresman, G. F. (2003) · Human Reproduction · doi:10.1093/humrep/deg356 · Cited by 92
Cited by
Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview
Wang, L.-T., Chen, L.-R., & Chen, K.-H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065814 · Cited by 166
Pharmacologic therapies in endometriosis: a systematic review
Soares, S. R., Martínez‐Varea, A., Hidalgo‐Mora, J. J., & Pellicer, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.07.1120 · Cited by 165
Medical Treatment of Uterine Leiomyoma
Sabry, M., & Al-Hendy, A. A. (2012) · Reproductive Sciences · doi:10.1177/1933719111432867 · Cited by 163
Diamond, M. P., Carr, B. R., Dmowski, W. P., Koltun, W. D., O'Brien, C. F., Jiang, P. X., Burke, J., Jimenez, R., Garner, E. I. O., & Chwalisż, K. (2014) · Reproductive Sciences · doi:10.1177/1933719113497292 · Cited by 128
An update on the pharmacological management of endometriosis
Streuli, I., de Ziegler, D., Santulli, P., Marcellin, L., Borghese, B., Batteux, F., & Chapron, C. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.767334 · Cited by 104
Carr, B., Dmowski, W. P., O’Brien, C., Jiang, P., Burke, J., Jimenez, R., Garner, E., & Chwalisz, K. (2014) · Reproductive Sciences · doi:10.1177/1933719114549848 · Cited by 114
“However, patients receiving progestin therapy may experience an increase in bothersome symptoms including irregular breakthrough bleeding, mood changes, and breast tenderness,(2-4) and add-back therapy is recommended with the use of GnRH agonists to avoid unacceptable hypoestrogenic side effects, including progressive…”
BackgroundGeorgiou, E. X., Melo, P., Baker, P. E., Sallam, H. N., Arici, A., Garcia-Velasco, J. A., Abou-Setta, A. M., Becker, C., & Granne, I. E. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013240.pub2 · Cited by 113
Al-Hendy, A. A., Roshdy, Rajaratnam, Maitra, S. R., Sabry, M., & Allah, A. (2013) · International Journal of Women s Health · doi:10.2147/ijwh.s41021 · Cited by 113
Medical Treatments for Endometriosis-Associated Pelvic Pain
Zito, G., Luppi, S., Giolo, E., Martinelli, M., Venturin, I., Di Lorenzo, G., & Ricci, G. (2014) · BioMed Research International · doi:10.1155/2014/191967 · Cited by 93
Endometriosis, a modern syndrome.
Brosens, I. A., & Benagiano, G. (2011) · PubMed Central · Cited by 103
Hormonal therapy for endometriosis: from molecular research to bedside
Tosti, C., Biscione, A., Morgante, G., Bifulco, G., Luisi, S., & Petraglia, F. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.05.032 · Cited by 96
DiVasta, A. D., Feldman, H. A., Sadler Gallagher, J., Stokes, N. A., Laufer, M. R., Hornstein, M. D., & Gordon, C. M. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000964 · Cited by 92
Sakr, S., Naqvi, H., Komm, B., & Taylor, H. S. (2014) · Endocrinology · doi:10.1210/en.2013-1977 · Cited by 91
GnRH agonists in the treatment of symptomatic endometriosis: a review
Surrey, E. S. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.11.009 · Cited by 72
Self-citationElagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study
Carr, B., Giudice, L., Dmowski, W. P., O'Brien, C., Jiang, P., Burke, J., Jimenez, R., Hass, S., Fuldeore, M., & Chwalisz, K. (2013) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/je.5000157 · Cited by 64
Progress in the diagnosis and management of adolescent endometriosis: an opinion
Benagiano, G., Guo, S., Puttemans, P., Gordts, S., & Brosens, I. A. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.09.015 · Cited by 69
Shea, K. L., Gavin, K. M., Melanson, E. L., Gibbons, E., Stavros, A., Wolfe, P., Kittelson, J. M., Vondracek, S. F., Schwartz, R. S., Wierman, M. E., et al. (2015) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000430 · Cited by 68
When more is not better: 10 ‘don’ts’ in endometriosis management. An ETIC* position statement
Club, E. E. T. I., Alio, L., Angioni, S., Arena, S., Bartiromo, L., Bergamini, V, Berlanda, N., Bonin, C., Busacca, M., Candiani, M., et al. (2019) · Human Reproduction Open · doi:10.1093/hropen/hoz009 · Cited by 64
Chwalisz, K., Surrey, E., & Stanczyk, F. Z. (2012) · Reproductive Sciences · doi:10.1177/1933719112438061 · Cited by 58
“Initially, a 6-month course of leuprolide acetate plus NETA 5 mg is recommended, with up to 6 months of additional therapy as needed for recurrence of symptoms.(4,10) The use of add-back therapy has been recommended by several national and international professional gynecological societies, including the American Coll…”
BackgroundMethodSelf-citationNaqvi, H., Sakr, S., Presti, T., Krikun, G., Komm, B., & Taylor, H. S. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.113.114165 · Cited by 54
Treatment of thoracic endometriosis syndrome: A meta-analysis and review
Ciriaco, P., Muriana, P., Lembo, R., Carretta, A., & Negri, G. (2022) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2020.09.064 · Cited by 47
Jeng, C.-J., Chuang, L., & Shen, J. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.888414 · Cited by 36
Conservative management of young patients with endometrial highly-differentiated adenocarcinoma
Kalogiannidis, I. A., & Αγοραστός, Θ. (2011) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2010.532249 · Cited by 34
Ács, N., O'Brien, C., Jiang, P., Burke, J., Jimenez, R., Garner, E., & Chwalisz, K. (2015) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/je.5000211 · Cited by 30
Gonadotrophin-releasing hormone analogues and endometriosis: current strategies and new insights
Hashim, H. A. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.650751 · Cited by 31
Bi, X.-L., & Xie, C. (2018) · Medicine · doi:10.1097/md.0000000000011266 · Cited by 30
Aromatase Inhibitors for Endometriosis-Associated Infertility; Do We Have Sufficient Evidence?
Hashim, H. A. (2016) · PubMed Central · doi:10.22074/ijfs.2016.5040 · Cited by 28
Low-dose add-back therapy during postoperative GnRH agonist treatment
Tsai, H.-W., Wang, P.-H., Huang, B.-S., Twu, N.-F., Yen, M.-S., & Chen, Y.-J. (2016) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2015.04.004 · Cited by 21
Emerging gonadotropin-releasing hormone agonists
Beyer, D. A., Amari, F., Thill, M., Schultze-Mosgau, A., Al‐Hasani, S., Diedrich, K., & Griesinger, G. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2010.547472 · Cited by 20
Clinical development of the GnRH agonist leuprolide acetate depot
Chwalisż, K. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.11.011 · Cited by 19
Guo, Y., Fang, Z., Yu, L., Sun, X., Li, F., & Jin, L. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01095-4 · Cited by 18
Minimising menopausal side effects whilst treating endometriosis and fibroids
Simpson, P. D., McLaren, J. S., RYMER, J. M., & Morris, E. (2015) · Post Reproductive Health · doi:10.1177/2053369114568440 · Cited by 13
The Double Engines and Single Checkpoint Theory of Endometriosis
Hsu, C.-F., Khine, A. A., Huang, H.-S., & Chu, T.-Y. (2022) · Biomedicines · doi:10.3390/biomedicines10061403 · Cited by 12
Matsushima, T., Akira, S., Asakura, H., & Takeshita, T. (2017) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog3214.2017 · Cited by 12
A Multimodal Approach to Symptomatic Endometriosis: A Proposed Algorithm for Clinical Management
Cetera, G. E., Merli, C. E. M., & Vercellini, P. (2025) · Reproductive Sciences · doi:10.1007/s43032-024-01763-w · Cited by 11
Endometriose: recomendações de consenso nacionais - tratamento médico
Carvalho, M. J., Barbosa, A., Couto, D., Geraldes, F., Vilhena, I. R., Reis, J. L., Damasceno, J., Figueiredo, S., & Águas, F. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 10
Future Directions in Endometriosis Research and Therapeutics
Nothnick, W. B., Marsh, C. A., & Alali, Z. (2018) · Current Women s Health Reviews · doi:10.2174/1573404813666161221164810 · Cited by 9
Bazedoxifene/conjugated estrogens in combination with leuprolide for the treatment of endometriosis
Hill, A., Lessey, B. A., Flores, V. A., & Taylor, H. S. (2018) · Clinical Case Reports · doi:10.1002/ccr3.1501 · Cited by 8
Jaafar, S. H., Sallam, H. N., Arici, A. M., García-Velasco, J. A., & Abou-Setta, A. M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013240 · Cited by 8
Beck, D., Winzenborg, I., Liu, M., Degner, J. F., Mostafa, N. M., Noertersheuser, P. A., & Shebley, M. (2021) · Clinical Pharmacokinetics · doi:10.1007/s40262-021-01096-w · Cited by 7
The Place of Gonadotropin-Releasing Hormone Agonists in the Management of Endometriosis
Descamps, P., En, A., Leng, J., Salehpour, S., & Chapron, C. (2014) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/je.5000174 · Cited by 6
Targeting c-MYC: a potential non-hormonal therapeutic approach for endometriosis treatment
Nothnick, W. B., Arachchige, S. P., Minchella, P. M., Stephens, E. B., & Graham, A. R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1225055 · Cited by 5
Paoletti, A. M., Neri, M., Pilloni, M., Marotto, M. F., Giancane, E., Vallerino, V., Piras, B., Melis, G., Melis, V., Masciale, M. D. M., et al. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2499550 · Cited by 5
Orive, A., Corachán, A., Escrig, J., Mascarell‐López, M. D. M., Pellicer, A., Monleón, J., & Ferrero, H. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70271 · Cited by 5
Análogos de la GnRH en el tratamiento de los miomas
Murillo, E. O., & Cano, A. (2013) · Medicina Clínica · doi:10.1016/s0025-7753(13)70051-4 · Cited by 5
Holt, V. L., Trabert, B. L., & Upson, K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384978-6.00018-2 · Cited by 6
Zou, S., Long, Q., Zhang, S., Han, Y., & Zhang, W. (2013) · Europe PMC (PubMed Central) · Cited by 5
A review of treatment options for chronic pelvic pain from endometriosis
Choi, S., & Tran, J. P. (2025) · Pain Management · doi:10.1080/17581869.2025.2542713 · Cited by 4
Zippl, A. L., Mohsin, W. S. Y., Gasser, E., Henninger, B., Widschwendter, A., Kafka‐Ritsch, R., & Seeber, B. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.05.001 · Cited by 4
Diagnosis and treatment of endometriosis
Kim, H., & Cho, S. (2019) · Journal of Korean Medical Association · doi:10.5124/jkma.2019.62.10.513 · Cited by 4
Novel Medical Treatment Modalities of Endometriosis
Uysal, G., Çağlı, F., Aksoy, H., Aksoy, Ü., Cıngıllıoğlu, B., Karakiliç, E. Ü., & Açmaz, G. (2015) · Kafkas Journal of Medical Sciences · doi:10.5505/kjms.2015.24572 · Cited by 4
Diagnosis and management of thoracic endometriosis syndrome: Case report
Shaw, A. M., DeMarco, K. M., Belovs, L., Strange, R., & Spitzer, T. (2023) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/22840265231170912 · Cited by 3
Insights on Medical Therapy for Uterine Fibroids: A Review
Pecorella, G., Morciano, A., Sparić, R., Hatırnaz, Ş., Medvediev, M. V., Malvası, A., Damiani, G. R., & Tinelli, A. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03539-x · Cited by 2
Maitrise de la folliculogenèse chez la chienne a l’aide d’agonistes de la GnRH
Fontaine, E. (2012) · theses.fr (ABES) · doi:10.70675/0a44a971zcb3ez423eza51ez940776002c36 · Cited by 2
Leiomiomas Uterinos: Tipos de Tratamiento
del Zulia, D. D. O. Y. G. U. D. Z. M. C. N. D. L. A. N. D. M. N. X. M. E. D. L. A. D. M., & Núñez-Troconis, J. (2025) · Gaceta Médica de Caracas · doi:10.47307/gmc.2025.133.1.17 · Cited by 1
Progestogens and Endometriosis
Carp, H., Soriano, D., & Zolti, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-14385-9_9 · Cited by 1
Joo, J. K., Jung, I. K., Kim, K. H., & Lee, K. S. (2012) · Korean Journal of Obstetrics & Gynecology · doi:10.5468/kjog.2012.55.6.371 · Cited by 1
Uterus-Sparing Treatment Options for the Management of Fibroids
Napoli, A., Scipione, R., Hanspeter, E., Marrocchio, C., Dababou, S., Andrani, F., Palla, C., Anzidei, M., Ciolina, F., Manganaro, L., et al. (2018) · Obstetrics and Gynaecology Cases - Reviews · doi:10.23937/2377-9004/1410131 · Cited by 1
Medical and Surgical Management of Endometriosis
Zupi, E., Lazzeri, L., & Exacoustós, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-71138-6_2 · Cited by 1
Long-Term Hormonal Treatment for Recurrent Catamenial Pneumothorax
Muneyyirci‐Delale, O., Persad, M. D., Tewari, H., Bowers, C., & Cutler, J. (2011) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/je.2011.8913
Medical management of symptomatic endometriosis: a new weapon in the arsenal?
Surrey, E. S. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.04.006
Self-citationGONADOTROPIN-RELEASING HORMONE AGONISTS IN ENDOMETRIOSIS TREATMENT AND IN VITRO FERTILIZATION
Lider‐Burciulescu, S., Sima, R., & Pleș, L. (2018) · Journal of Surgical Sciences · doi:10.33695/jss.v1i3.190
Alali, Z. (2018) · KU ScholarWorks (The University of Kansas)
Cieri‐Hutcherson, N. E., Carden, D., & Hutcherson, T. C. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.endometriosis_overview
Guo, Y., Fang, Z., Yu, L., Sun, X., Li, F., & Jin, L. (2023) · Figshare · doi:10.6084/m9.figshare.22608991
Analyse des Proteinmusters der epithelialen Drüsen im Endometrium und bei der Endometriose
Nurzay, H., & Justus Liebig University Giessen (2017) · University writing server of the Justus Liebig University Giessen (Justus-Liebig-Universität Gießen) · doi:10.22029/jlupub-14598
Medical management of endometriosis
Mishra, A., & Arya, P. (2018) · International Journal of Pharmacological Research
GnRH Analogues for the Treatment of Endometriosis-Related Pain: A Narrative Review
Anastasiu, C. V., Dimienescu, O. G., Dull, A.-M., Grigorescu, O. D., Canditu, I., & Moga, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145440
Panchal, R., Kumari, D., Chaudhary, P., Janmeda, P., & Prakash, A. (2026) · Nutrition and Health · doi:10.1177/02601060261491806
Pecorella, G., Morciano, A., & Tinelli, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27757-3.00017-1
Metadata
- Authors
- Surrey, E. S.
- Affiliations
- Colorado Center for Reproductive Medicine (US)
- Corresponding author
- Surrey, Eric S
- ORCID
- Surrey, Eric S
- Venue
- Current Opinion in Obstetrics & Gynecology
- Published
- 2010-08
- Volume
- 22
- Issue
- 4
- Pages
- 283-288
- ISSN
- 1040-872X (ISSN-L)
- OpenAlex
- W2036733694
- Cited by
- 64
- References
- 36
- Citations by year
- 2026: 3 · 2025: 4 · 2023: 5 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 4 · 2018: 7 · 2017: 3 · 2016: 3 · 2015: 6 · 2014: 6 · 2013: 6 · 2012: 6
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Obstetrics & Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- endometriosis, GnRH agonist, add-back therapy, norethindrone acetate, progestins, low-dose estrogen, medication adherence, vasomotor symptoms, bone loss, bone mineral density, adolescents, infertility, chronic pelvic pain
- MeSH terms
- Adolescent, Adult, Endometriosis, Estrogens, Female, Humans, Gonadotropin-Releasing Hormone, Osteoporosis, Progestins, Hormone Replacement Therapy, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.